Brian Schliesman is the Director of Sales and Business Development at Kamiya Biomedical Company. He has a long history with the company, focusing on the biomedical diagnostics market and handling key regulatory correspondence for immunoassay products.
He served as the official company correspondent to the FDA for the approval of a key C-Reactive Protein diagnostic assay.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.